LATS1/2 (Phospho-Thr1079/1041) Antibody

To Order:  patrick@cotinis.com

LATS1/2 (Phospho-Thr1079/1041) Polyclonal Antibody

ABP59095-003ml 0.03ml
EUR 189.6
Description: A polyclonal antibody for detection of LATS1/2 Phospho-Thr1079/1041) from Human, Mouse, Rat. This LATS1/2 Phospho-Thr1079/1041) antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human LATS1/2 (Phospho-Thr1079/1041) Antibody protein

LATS1/2 (Phospho-Thr1079/1041) Polyclonal Antibody

ABP59095-01ml 0.1ml
EUR 346.8
Description: A polyclonal antibody for detection of LATS1/2 Phospho-Thr1079/1041) from Human, Mouse, Rat. This LATS1/2 Phospho-Thr1079/1041) antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human LATS1/2 (Phospho-Thr1079/1041) Antibody protein

LATS1/2 (Phospho-Thr1079/1041) Polyclonal Antibody

ABP59095-02ml 0.2ml
EUR 496.8
Description: A polyclonal antibody for detection of LATS1/2 Phospho-Thr1079/1041) from Human, Mouse, Rat. This LATS1/2 Phospho-Thr1079/1041) antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human LATS1/2 (Phospho-Thr1079/1041) Antibody protein

LATS1/2 (phospho Thr1079/1041) Polyclonal Antibody

ES7961-100ul 100ul
EUR 334.8
Description: A Rabbit Polyclonal antibody against LATS1/2 (phospho Thr1079/1041) from Human/Mouse. This antibody is tested and validated for IHC, WB, ELISA

LATS1/2 (phospho Thr1079/1041) Polyclonal Antibody

ES7961-50ul 50ul
EUR 248.4
Description: A Rabbit Polyclonal antibody against LATS1/2 (phospho Thr1079/1041) from Human/Mouse. This antibody is tested and validated for IHC, WB, ELISA

Anti-Phospho-LATS1/2 (Thr1079/1041) antibody

STJ99599 200 µl
EUR 236.4
Description: Rabbit polyclonal to Phospho-LATS1/2 (Thr1079/1041).

Phospho-LATS1/LATS2 (Thr1079/1041) Antibody

CSB-PA905508-
EUR 402
Description: A polyclonal antibody against Phospho-LATS1/LATS2 (Thr1079/1041). Recognizes Phospho-LATS1/LATS2 (Thr1079/1041) from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;IHC:1:50-1:100

Phospho-LATS1/LATS2 (Thr1079/1041) Antibody

CSB-PA905508-100ul 100ul
EUR 434.4
Description: A polyclonal antibody against Phospho-LATS1/LATS2 (Thr1079/1041). Recognizes Phospho-LATS1/LATS2 (Thr1079/1041) from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;IHC:1:50-1:100

LATS1/2 (Phospho-Thr1079/1041) Polyclonal Conjugated Antibody

C11736 100ul
EUR 476.4

LATS1 (Phospho-Thr1079) Antibody

13032-100ul 100ul
EUR 302.4

LATS1 (Phospho-Thr1079) Antibody

13032-50ul 50ul
EUR 224.4

Phospho- LATS1 (Thr1079) Antibody

ABF3638 100 ug
EUR 525.6

Phospho-LATS1 (Thr1079) Antibody

AF7169 200ul
EUR 540

MethylFlash 5-Formylcytosine (5-fC) DNA Quantification Kit (Colorimetric) 

P-1041
  • EUR 1137.06
  • EUR 442.20
  • EUR 760.10
  • 96 Assays
  • 48 Assays
  • 96 Assays

LATS1 (Phospho-Thr1079) Conjugated Antibody

C13032 100ul
EUR 476.4

Phospho-LATS1 (Thr1079) Blocking Peptide

AF7169-BP 1mg
EUR 234

LATS antibody (Thr1079/1041)

70R-32663 100 ug
EUR 392.4
Description: Rabbit polyclonal LATS antibody (Thr1079/1041)

Anti-Phospho-LATS1/2 (T1079/1041) antibody

STJ91207 200 µl
EUR 236.4
Description: Rabbit polyclonal to Phospho-LATS1/2 (T1079/1041).

Phospho-LATS1/LATS2 (T1079/1041) Antibody

1-CSB-PA070231
  • EUR 266.40
  • EUR 234.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against Phospho-LATS1/LATS2 (T1079/1041). Recognizes Phospho-LATS1/LATS2 (T1079/1041) from Human, Mouse. This antibody is Unconjugated. Tested in the following application: IHC, ELISA;IHC:1/100-1/300.ELISA:1/20000

LATS1 / LATS2 (pT1079 / 1041) Antibody

abx332955-100ul 100 ul
EUR 560.4

LATS1 / LATS2 (pT1079 / 1041) Antibody

20-abx325183
  • EUR 376.80
  • EUR 292.80
  • 100 ug
  • 50 ug

Anti-LATS1 Antibody

A01051-2 100ug/vial
EUR 400.8

LATS1/2 (Phospho-Ser909/872) Antibody

12514-100ul 100ul
EUR 302.4

LATS1/2 (Phospho-Ser909/872) Antibody

12514-50ul 50ul
EUR 224.4

LATS1/2 (Phospho- Ser909/872) Antibody

ABF8163 100 ug
EUR 525.6

Phospho-LATS1/2 (Ser909/Ser872) Antibody

AF8163 200ul
EUR 540

LATS1 (Phospho-Ser909) Antibody

13033-100ul 100ul
EUR 302.4

LATS1 (Phospho-Ser909) Antibody

13033-50ul 50ul
EUR 224.4

LATS1 (Phospho-Tyr283) Antibody

13034-100ul 100ul
EUR 302.4

LATS1 (Phospho-Tyr283) Antibody

13034-50ul 50ul
EUR 224.4

Phospho-LATS1 (Ser909) Antibody

AF7170 200ul
EUR 540

Phospho-LATS1 (Tyr283) Antibody

AF7171 200ul
EUR 540

LATS1/2 Antibody

33232-100ul 100ul
EUR 302.4

LATS1/2 Antibody

33232-50ul 50ul
EUR 224.4

LATS1/2 Antibody

DF7517 200ul
EUR 420

LATS1 (Phospho-Ser909) Conjugated Antibody

C13033 100ul
EUR 476.4

LATS1 (Phospho-Tyr283) Conjugated Antibody

C13034 100ul
EUR 476.4

LATS1/2 (Phospho-Ser909/872) Polyclonal Conjugated Antibody

C12514 100ul
EUR 476.4

Serine/threonine-Protein Kinase LATS1/2 (LATS1/2) Antibody

20-abx141092
  • EUR 427.20
  • EUR 644.40
  • EUR 260.40
  • 100 ul
  • 200 ul
  • 30 ul

Serine/threonine-Protein Kinase LATS1/2 (LATS1/2) Antibody

20-abx012918
  • EUR 376.80
  • EUR 117.60
  • EUR 477.60
  • EUR 594.00
  • 100 ug
  • 10 ug
  • 200 ug
  • 300 µg

Phospho-LATS1/2 (Ser909/872) Blocking Peptide

AF8163-BP 1mg
EUR 234

Anti-LATS1/2 Antibody

A01051 100ul
EUR 476.4
Description: Rabbit Polyclonal LATS1/2 Antibody. Validated in IHC and tested in Human.

Anti-LATS1/2 Antibody

A01051-1 100ul
EUR 476.4
Description: Rabbit Polyclonal Antibody for LATS1/2 Antibody (LATS1) detection.tested for WB in Human, Mouse.

LATS1/2 Polyclonal Antibody

ABP51705-003ml 0.03ml
EUR 189.6
Description: A polyclonal antibody for detection of LATS1/2 from Human, Mouse. This LATS1/2 antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human LATS1/2 around the non-phosphorylation site of T1079/1041

LATS1/2 Polyclonal Antibody

ABP51705-01ml 0.1ml
EUR 346.8
Description: A polyclonal antibody for detection of LATS1/2 from Human, Mouse. This LATS1/2 antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human LATS1/2 around the non-phosphorylation site of T1079/1041

LATS1/2 Polyclonal Antibody

ABP51705-02ml 0.2ml
EUR 496.8
Description: A polyclonal antibody for detection of LATS1/2 from Human, Mouse. This LATS1/2 antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human LATS1/2 around the non-phosphorylation site of T1079/1041

LATS1/2 Polyclonal Antibody

ABP59096-003ml 0.03ml
EUR 189.6
Description: A polyclonal antibody for detection of LATS1/2 from Human, Mouse, Rat. This LATS1/2 antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human LATS1/2 antibody protein

LATS1/2 Polyclonal Antibody

ABP59096-01ml 0.1ml
EUR 346.8
Description: A polyclonal antibody for detection of LATS1/2 from Human, Mouse, Rat. This LATS1/2 antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human LATS1/2 antibody protein

LATS1/2 Polyclonal Antibody

ABP59096-02ml 0.2ml
EUR 496.8
Description: A polyclonal antibody for detection of LATS1/2 from Human, Mouse, Rat. This LATS1/2 antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human LATS1/2 antibody protein

LATS1/2 Conjugated Antibody

C33232 100ul
EUR 476.4

LATS1/2 Polyclonal Antibody

ES2704-100ul 100ul
EUR 334.8
Description: A Rabbit Polyclonal antibody against LATS1/2 from Human/Mouse. This antibody is tested and validated for WB, ELISA, IHC, WB, ELISA

LATS1/2 Polyclonal Antibody

ES2704-50ul 50ul
EUR 248.4
Description: A Rabbit Polyclonal antibody against LATS1/2 from Human/Mouse. This antibody is tested and validated for WB, ELISA, IHC, WB, ELISA

Anti-LATS1/2 antibody

STJ93908 200 µl
EUR 236.4
Description: Rabbit polyclonal to LATS1/2.

Anti-LATS1/2 antibody

STJ99623 200 µl
EUR 236.4
Description: Rabbit polyclonal to LATS1/2.

Phospho-LATS1 (Ser909) Blocking Peptide

AF7170-BP 1mg
EUR 234

Phospho-LATS1 (Tyr283) Blocking Peptide

AF7171-BP 1mg
EUR 234

LATS1 antibody

70R-18222 50 ul
EUR 522
Description: Rabbit polyclonal LATS1 antibody

LATS1 antibody

70R-51351 100 ul
EUR 292.8
Description: Purified Polyclonal LATS1 antibody

LATS1 antibody

70R-5683 50 ug
EUR 560.4
Description: Rabbit polyclonal LATS1 antibody

LATS1 Antibody

36187-100ul 100ul
EUR 302.4

lats1 Antibody

ABD7517 100 ug
EUR 525.6

LATS1 Antibody

AF7669 200ul
EUR 540

LATS1 Antibody

AF7670 200ul
EUR 540

LATS1 Antibody

AF7671 200ul
EUR 540

LATS1 Antibody

1-CSB-PA830665
  • EUR 380.40
  • EUR 292.80
  • 100ul
  • 50ul
Description: A polyclonal antibody against LATS1. Recognizes LATS1 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:2000-1:5000, IHC:1:25-1:100

LATS1 Antibody

1-CSB-PA012769GA01HU
  • EUR 716.40
  • EUR 399.60
  • 150ul
  • 50ul
Description: A polyclonal antibody against LATS1. Recognizes LATS1 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB

LATS1 Antibody

1-CSB-PA012769LA01HU
  • EUR 380.40
  • EUR 402.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against LATS1. Recognizes LATS1 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC, IF, IP; Recommended dilution: IHC:1:20-1:200, IF:1:50-1:500, IP:1:200-1:2000

LATS1 Antibody

RQ4584 100ug
EUR 419

LATS1 Antibody

F50049-0.08ML 0.08 ml
EUR 165

LATS1 Antibody

F50049-0.4ML 0.4 ml
EUR 379

Anti-phospho-LATS1-S909/LATS2-S872 antibody

STJ11101017 50 µl
EUR 471.6
Description: The protein encoded by this gene is a putative serine/threonine kinase that localizes to the mitotic apparatus and complexes with cell cycle controller CDC2 kinase in early mitosis. The protein is phosphorylated in a cell-cycle dependent manner, with late prophase phosphorylation remaining through metaphase. The N-terminal region of the protein binds CDC2 to form a complex showing reduced H1 histone kinase activity, indicating a role as a negative regulator of CDC2/cyclin A. In addition, the C-terminal kinase domain binds to its own N-terminal region, suggesting potential negative regulation through interference with complex formation via intramolecular binding. Biochemical and genetic data suggest a role as a tumor suppressor. This is supported by studies in knockout mice showing development of soft-tissue sarcomas, ovarian stromal cell tumors and a high sensitivity to carcinogenic treatments.

Anti-phospho-LATS1-T1079/LATS2-T1041 antibody

STJ11101018 50 µl
EUR 471.6
Description: The protein encoded by this gene is a putative serine/threonine kinase that localizes to the mitotic apparatus and complexes with cell cycle controller CDC2 kinase in early mitosis. The protein is phosphorylated in a cell-cycle dependent manner, with late prophase phosphorylation remaining through metaphase. The N-terminal region of the protein binds CDC2 to form a complex showing reduced H1 histone kinase activity, indicating a role as a negative regulator of CDC2/cyclin A. In addition, the C-terminal kinase domain binds to its own N-terminal region, suggesting potential negative regulation through interference with complex formation via intramolecular binding. Biochemical and genetic data suggest a role as a tumor suppressor. This is supported by studies in knockout mice showing development of soft-tissue sarcomas, ovarian stromal cell tumors and a high sensitivity to carcinogenic treatments.

Anti-phospho-LATS1-S909/LATS2-S872 antibody

STJ11101039 100 µl
EUR 471.6
Description: The protein encoded by this gene is a putative serine/threonine kinase that localizes to the mitotic apparatus and complexes with cell cycle controller CDC2 kinase in early mitosis. The protein is phosphorylated in a cell-cycle dependent manner, with late prophase phosphorylation remaining through metaphase. The N-terminal region of the protein binds CDC2 to form a complex showing reduced H1 histone kinase activity, indicating a role as a negative regulator of CDC2/cyclin A. In addition, the C-terminal kinase domain binds to its own N-terminal region, suggesting potential negative regulation through interference with complex formation via intramolecular binding. Biochemical and genetic data suggest a role as a tumor suppressor. This is supported by studies in knockout mice showing development of soft-tissue sarcomas, ovarian stromal cell tumors and a high sensitivity to carcinogenic treatments.

Anti-phospho-LATS1-T1079/LATS2-T1041 antibody

STJ11101047 100 µl
EUR 471.6
Description: The protein encoded by this gene is a putative serine/threonine kinase that localizes to the mitotic apparatus and complexes with cell cycle controller CDC2 kinase in early mitosis. The protein is phosphorylated in a cell-cycle dependent manner, with late prophase phosphorylation remaining through metaphase. The N-terminal region of the protein binds CDC2 to form a complex showing reduced H1 histone kinase activity, indicating a role as a negative regulator of CDC2/cyclin A. In addition, the C-terminal kinase domain binds to its own N-terminal region, suggesting potential negative regulation through interference with complex formation via intramolecular binding. Biochemical and genetic data suggest a role as a tumor suppressor. This is supported by studies in knockout mice showing development of soft-tissue sarcomas, ovarian stromal cell tumors and a high sensitivity to carcinogenic treatments.

LATS1 / 2 (pS909 / 872) Antibody

abx216529-100ug 100 ug
EUR 526.8

LATS1 / 2 Blocking Peptide

20-abx061790
  • EUR 309.60
  • EUR 460.80
  • 1 mg
  • 5 mg

lats1/2 Blocking Peptide

DF7517-BP 1mg
EUR 234

TRIM29(TRIM29/1041) Antibody

BNC041041-100 100uL
EUR 238.8
Description: Primary antibody against TRIM29(TRIM29/1041), CF405S conjugate, Concentration: 0.1mg/mL

TRIM29(TRIM29/1041) Antibody

BNC041041-500 500uL
EUR 652.8
Description: Primary antibody against TRIM29(TRIM29/1041), CF405S conjugate, Concentration: 0.1mg/mL

TRIM29(TRIM29/1041) Antibody

BNCAP1041-100 100uL
EUR 238.8
Description: Primary antibody against TRIM29(TRIM29/1041), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

TRIM29(TRIM29/1041) Antibody

BNCAP1041-500 500uL
EUR 652.8
Description: Primary antibody against TRIM29(TRIM29/1041), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

TRIM29(TRIM29/1041) Antibody

BNCB1041-100 100uL
EUR 238.8
Description: Primary antibody against TRIM29(TRIM29/1041), Biotin conjugate, Concentration: 0.1mg/mL

TRIM29(TRIM29/1041) Antibody

BNCB1041-500 500uL
EUR 652.8
Description: Primary antibody against TRIM29(TRIM29/1041), Biotin conjugate, Concentration: 0.1mg/mL

TRIM29(TRIM29/1041) Antibody

BNCP1041-250 250uL
EUR 459.6
Description: Primary antibody against TRIM29(TRIM29/1041), PerCP conjugate, Concentration: 0.1mg/mL

TRIM29(TRIM29/1041) Antibody

BNCR1041-250 250uL
EUR 459.6
Description: Primary antibody against TRIM29(TRIM29/1041), RPE conjugate, Concentration: 0.1mg/mL

TRIM29(TRIM29/1041) Antibody

BNC941041-100 100uL
EUR 238.8
Description: Primary antibody against TRIM29(TRIM29/1041), CF594 conjugate, Concentration: 0.1mg/mL

TRIM29(TRIM29/1041) Antibody

BNC941041-500 500uL
EUR 652.8
Description: Primary antibody against TRIM29(TRIM29/1041), CF594 conjugate, Concentration: 0.1mg/mL

TRIM29(TRIM29/1041) Antibody

BNCA1041-250 250uL
EUR 459.6
Description: Primary antibody against TRIM29(TRIM29/1041), APC conjugate, Concentration: 0.1mg/mL

TRIM29(TRIM29/1041) Antibody

BNC811041-100 100uL
EUR 238.8
Description: Primary antibody against TRIM29(TRIM29/1041), CF680R conjugate, Concentration: 0.1mg/mL

TRIM29(TRIM29/1041) Antibody

BNC811041-500 500uL
EUR 652.8
Description: Primary antibody against TRIM29(TRIM29/1041), CF680R conjugate, Concentration: 0.1mg/mL

TRIM29(TRIM29/1041) Antibody

BNUB1041-100 100uL
EUR 250.8
Description: Primary antibody against TRIM29(TRIM29/1041), Concentration: 0.2mg/mL

TRIM29(TRIM29/1041) Antibody

BNUB1041-500 500uL
EUR 549.6
Description: Primary antibody against TRIM29(TRIM29/1041), Concentration: 0.2mg/mL

TRIM29(TRIM29/1041) Antibody

BNCH1041-100 100uL
EUR 238.8
Description: Primary antibody against TRIM29(TRIM29/1041), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

TRIM29(TRIM29/1041) Antibody

BNCH1041-500 500uL
EUR 652.8
Description: Primary antibody against TRIM29(TRIM29/1041), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

TRIM29(TRIM29/1041) Antibody

BNC881041-100 100uL
EUR 238.8
Description: Primary antibody against TRIM29(TRIM29/1041), CF488A conjugate, Concentration: 0.1mg/mL

TRIM29(TRIM29/1041) Antibody

BNC881041-500 500uL
EUR 652.8
Description: Primary antibody against TRIM29(TRIM29/1041), CF488A conjugate, Concentration: 0.1mg/mL

TRIM29(TRIM29/1041) Antibody

BNC681041-100 100uL
EUR 238.8
Description: Primary antibody against TRIM29(TRIM29/1041), CF568 conjugate, Concentration: 0.1mg/mL

TRIM29(TRIM29/1041) Antibody

BNC681041-500 500uL
EUR 652.8
Description: Primary antibody against TRIM29(TRIM29/1041), CF568 conjugate, Concentration: 0.1mg/mL

TRIM29(TRIM29/1041) Antibody

BNC471041-100 100uL
EUR 238.8
Description: Primary antibody against TRIM29(TRIM29/1041), CF647 conjugate, Concentration: 0.1mg/mL

TRIM29(TRIM29/1041) Antibody

BNC471041-500 500uL
EUR 652.8
Description: Primary antibody against TRIM29(TRIM29/1041), CF647 conjugate, Concentration: 0.1mg/mL

TRIM29(TRIM29/1041) Antibody

BNC401041-100 100uL
EUR 238.8
Description: Primary antibody against TRIM29(TRIM29/1041), CF640R conjugate, Concentration: 0.1mg/mL

TRIM29(TRIM29/1041) Antibody

BNC401041-500 500uL
EUR 652.8
Description: Primary antibody against TRIM29(TRIM29/1041), CF640R conjugate, Concentration: 0.1mg/mL

TRIM29(TRIM29/1041) Antibody

BNC431041-100 100uL
EUR 238.8
Description: Primary antibody against TRIM29(TRIM29/1041), CF543 conjugate, Concentration: 0.1mg/mL

TRIM29(TRIM29/1041) Antibody

BNC431041-500 500uL
EUR 652.8
Description: Primary antibody against TRIM29(TRIM29/1041), CF543 conjugate, Concentration: 0.1mg/mL

TRIM29(TRIM29/1041) Antibody

BNC551041-100 100uL
EUR 238.8
Description: Primary antibody against TRIM29(TRIM29/1041), CF555 conjugate, Concentration: 0.1mg/mL

TRIM29(TRIM29/1041) Antibody

BNC551041-500 500uL
EUR 652.8
Description: Primary antibody against TRIM29(TRIM29/1041), CF555 conjugate, Concentration: 0.1mg/mL

TRIM29(TRIM29/1041) Antibody

BNC611041-100 100uL
EUR 238.8
Description: Primary antibody against TRIM29(TRIM29/1041), CF660R conjugate, Concentration: 0.1mg/mL

TRIM29(TRIM29/1041) Antibody

BNC611041-500 500uL
EUR 652.8
Description: Primary antibody against TRIM29(TRIM29/1041), CF660R conjugate, Concentration: 0.1mg/mL

TRIM29(TRIM29/1041) Antibody

BNC801041-100 100uL
EUR 238.8
Description: Primary antibody against TRIM29(TRIM29/1041), CF680 conjugate, Concentration: 0.1mg/mL

TRIM29(TRIM29/1041) Antibody

BNC801041-500 500uL
EUR 652.8
Description: Primary antibody against TRIM29(TRIM29/1041), CF680 conjugate, Concentration: 0.1mg/mL

TRIM29(TRIM29/1041) Antibody

BNC051041-100 100uL
EUR 238.8
Description: Primary antibody against TRIM29(TRIM29/1041), CF405M conjugate, Concentration: 0.1mg/mL

TRIM29(TRIM29/1041) Antibody

BNC051041-500 500uL
EUR 652.8
Description: Primary antibody against TRIM29(TRIM29/1041), CF405M conjugate, Concentration: 0.1mg/mL

TRIM29(TRIM29/1041) Antibody

BNC701041-100 100uL
EUR 238.8
Description: Primary antibody against TRIM29(TRIM29/1041), CF770 conjugate, Concentration: 0.1mg/mL

TRIM29(TRIM29/1041) Antibody

BNC701041-500 500uL
EUR 652.8
Description: Primary antibody against TRIM29(TRIM29/1041), CF770 conjugate, Concentration: 0.1mg/mL

TRIM29(TRIM29/1041) Antibody

BNUM1041-50 50uL
EUR 474
Description: Primary antibody against TRIM29(TRIM29/1041), 1mg/mL

SARS-CoV-2 Nucleocapsid Protein, Avi-His-tag

E80027
  • EUR 635.80
  • EUR 4087.60
  • 1 ml
  • 100 ul

Recombinant SARS-CoV-2 Spike Glycoprotein(S) (D614G), Partial

E80028
  • EUR 388.30
  • EUR 860.20
  • 20 ul
  • 100 ul

SARS-CoV-2 Spike S1 RBD Protein, Avi-His-tag

E80024
  • EUR 635.80
  • EUR 4995.10
  • 100 ul
  • 1 ml

SARS-CoV-2 Spike S1 RBD Protein, Mouse Fc-fusion

E80026
  • EUR 588.50
  • EUR 823.90
  • 20 ul
  • 50 ul

LATS1 / LATS2 Antibody

abx331369-100ul 100 ul
EUR 510

LATS1 / LATS2 Antibody

20-abx325262
  • EUR 376.80
  • EUR 292.80
  • 100 ug
  • 50 ug

LATS1/LATS2 Antibody

CSB-PA069135-
EUR 402
Description: A polyclonal antibody against LATS1/LATS2. Recognizes LATS1/LATS2 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;IHC:1:50-1:100

LATS1/LATS2 Antibody

CSB-PA069135-100ul 100ul
EUR 379.2
Description: A polyclonal antibody against LATS1/LATS2. Recognizes LATS1/LATS2 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;IHC:1:50-1:100

LATS1 Conjugated Antibody

C36187 100ul
EUR 476.4

LATS1/LATS2 Antibody

1-CSB-PA003141
  • EUR 266.40
  • EUR 234.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against LATS1/LATS2. Recognizes LATS1/LATS2 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: WB, IHC, ELISA;IHC:1/100-1/300.ELISA:1/40000

Anti-LATS1 antibody

PAab04708 100 ug
EUR 426

anti- LATS1 antibody

FNab04708 100µg
EUR 606.3
Description: Antibody raised against LATS1

Anti-LATS1 antibody

STJ11100931 100 µl
EUR 471.6
Description: The protein encoded by this gene is a putative serine/threonine kinase that localizes to the mitotic apparatus and complexes with cell cycle controller CDC2 kinase in early mitosis. The protein is phosphorylated in a cell-cycle dependent manner, with late prophase phosphorylation remaining through metaphase. The N-terminal region of the protein binds CDC2 to form a complex showing reduced H1 histone kinase activity, indicating a role as a negative regulator of CDC2/cyclin A. In addition, the C-terminal kinase domain binds to its own N-terminal region, suggesting potential negative regulation through interference with complex formation via intramolecular binding. Biochemical and genetic data suggest a role as a tumor suppressor. This is supported by studies in knockout mice showing development of soft-tissue sarcomas, ovarian stromal cell tumors and a high sensitivity to carcinogenic treatments.

Anti-LATS1 antibody

STJ119966 100 µl
EUR 332.4
Description: The protein encoded by this gene is a putative serine/threonine kinase that localizes to the mitotic apparatus and complexes with cell cycle controller CDC2 kinase in early mitosis. The protein is phosphorylated in a cell-cycle dependent manner, with late prophase phosphorylation remaining through metaphase. The N-terminal region of the protein binds CDC2 to form a complex showing reduced H1 histone kinase activity, indicating a role as a negative regulator of CDC2/cyclin A. In addition, the C-terminal kinase domain binds to its own N-terminal region, suggesting potential negative regulation through interference with complex formation via intramolecular binding. Biochemical and genetic data suggest a role as a tumor suppressor. This is supported by studies in knockout mice showing development of soft-tissue sarcomas, ovarian stromal cell tumors and a high sensitivity to carcinogenic treatments.

SARS-CoV-2 Spike S1 (16-685) Protein, Avi-His-tag

E80021
  • EUR 635.80
  • EUR 4276.80
  • 100 ul
  • 1 ml

SARS-CoV-2 Spike S1 RBD (V367F) Protein, Avi-His-tag

E80023
  • EUR 635.80
  • EUR 3934.70
  • 100 ul
  • 1 ml

 

Scroll to Top